1. Home
  2. SCNI vs BKYI Comparison

SCNI vs BKYI Comparison

Compare SCNI & BKYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • BKYI
  • Stock Information
  • Founded
  • SCNI 2003
  • BKYI 1993
  • Country
  • SCNI Israel
  • BKYI United States
  • Employees
  • SCNI N/A
  • BKYI N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • BKYI Computer Software: Prepackaged Software
  • Sector
  • SCNI Health Care
  • BKYI Technology
  • Exchange
  • SCNI Nasdaq
  • BKYI Nasdaq
  • Market Cap
  • SCNI 3.5M
  • BKYI 3.2M
  • IPO Year
  • SCNI N/A
  • BKYI 1997
  • Fundamental
  • Price
  • SCNI $2.84
  • BKYI $0.94
  • Analyst Decision
  • SCNI
  • BKYI
  • Analyst Count
  • SCNI 0
  • BKYI 0
  • Target Price
  • SCNI N/A
  • BKYI N/A
  • AVG Volume (30 Days)
  • SCNI 12.9K
  • BKYI 6.3M
  • Earning Date
  • SCNI 11-29-2024
  • BKYI 11-14-2024
  • Dividend Yield
  • SCNI N/A
  • BKYI N/A
  • EPS Growth
  • SCNI N/A
  • BKYI N/A
  • EPS
  • SCNI N/A
  • BKYI N/A
  • Revenue
  • SCNI $284,000.00
  • BKYI $7,292,394.00
  • Revenue This Year
  • SCNI N/A
  • BKYI N/A
  • Revenue Next Year
  • SCNI N/A
  • BKYI $24.64
  • P/E Ratio
  • SCNI N/A
  • BKYI N/A
  • Revenue Growth
  • SCNI N/A
  • BKYI N/A
  • 52 Week Low
  • SCNI $2.23
  • BKYI $0.52
  • 52 Week High
  • SCNI $8.92
  • BKYI $4.50
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 30.31
  • BKYI 45.22
  • Support Level
  • SCNI $2.91
  • BKYI $1.13
  • Resistance Level
  • SCNI $3.70
  • BKYI $1.31
  • Average True Range (ATR)
  • SCNI 0.21
  • BKYI 0.17
  • MACD
  • SCNI -0.07
  • BKYI -0.01
  • Stochastic Oscillator
  • SCNI 7.37
  • BKYI 1.93

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.

About BKYI BIO-key International Inc.

BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

Share on Social Networks: